Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1

Status

Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Ductal Adenocarcinoma 1

Interventions

Cisplatin 130Radiotherapy 94Carboplatin 85Fluorouracil 79Paclitaxel 78Cyclophosphamide 77Gemcitabine 72Capecitabine 66Docetaxel 65Doxorubicin 60Oxaliplatin 59Etoposide 57Leucovorin 50Vincristine 47Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 31Epirubicin 29Neoadjuvant Therapy 28Pemetrexed 27Tamoxifen 25Irinotecan 25Prednisone 24Rituximab 21Methotrexate 21Radiotherapy, Intensity-Modulated 19apatinib 18Vinorelbine 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Pancreaticoduodenectomy × Clear all
NCT03317886 2017-10-24

Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer

Wakayama Medical University

Phase 3 Unknown
354 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡